Edwards Lifesciences Corp (NYSE:EW) currently has a daily average trading volume of 7.05M but it saw 5358747 shares traded in last market. With a market cap of 42.54B USD, the company’s current market price of $70.61 came rising about 1.98 while comparing to the previous closing price of $69.24. In past 52 weeks, the stock remained buoying in the range of price level as high as $96.12 and as low as $58.93. In the recent trading on the day, stock has struck highest price mark of $68.87 while lowest mark touched by it was $70.68.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which resumed the stock as “Equal-Weight” in its note to investors issued on October 11, 2024, recommending a price target of $70 for it. Jefferies downgraded its recommendation for the stock as a “Hold” from “Buy” on September 18, 2024 while assigning a price target range of $85-$70.
Over the week, EW’s stock price is moving 3.38% up while it is 6.45% when we observe its performance for the past one month. Year-to-date it is -7.40% down and over the past year, the stock is showing an upside performance of 2.26%.
Currently, Edwards Lifesciences Corp’s total number of outstanding shares is 601.10M. Company’s return on investment (ROI) stands at 18.17% and return on equity (ROE) at 21.35%. It has a price to earnings ratio (P/E ratio) of 29.06 while having a 27.02 of forward P/E ratio. Stock’s beta reads 1.13. Stock has a price to book (P/B) ratio of 5.72 while price to sale or P/S ratio amounts to 7.09. Its return on asset (ROA) is 15.44% on average.
